Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

15.04.2020 | short review

My personal highlights of ESMO 2019 regarding urogenital cancer

verfasst von: Dora Niedersüß-Beke

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Summary

The field of uro-oncology has become more and more important in the past 3 years. ESMO 2019 once again had more highlights in this growing field of medical oncology. The 2019 ESMO annual meeting was an outstanding conference, especially in uro-oncology. Trials with potential for changing the standard of care and novel therapy approaches were presented in bladder cancer and renal cell carcinoma.
Vorheriger Artikel ESMO 2019—personal highlights in gastrointestinal cancer
Nächster Artikel The role of pathology in sarcoma
Literatur
1.
Grande E, Galsky M, Arranz Arija JA, et al. IMvigor130: efficacy and safety from a phase 3 study of Atezolizumab as Monotherapy or combined with platinum-based chemotherapy vs placebo + PBC in previously untreated locally advanced or metastatic Urothelial carcinoma. Ann Oncol. 2019; https://​doi.​org/​10.​1093/​annonc/​mdz394.​047.CrossRef
2.
3.
4.
5.
6.
Metadaten
Titel
My personal highlights of ESMO 2019 regarding urogenital cancer
verfasst von
Dora Niedersüß-Beke
Publikationsdatum
15.04.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00605-0

Weitere Artikel der Ausgabe 2/2020

The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?

  • Open Access
  • short review

ESMO 2019: breast cancer

  • Open Access
  • short review

Therapy management in bone sarcoma

  • Open Access
  • short review

The intestinal microbiota and hepatocellular carcinoma

  • Open Access
  • review

ESMO 2019—personal highlights in gastrointestinal cancer

  • Open Access
  • short review

Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation

  • original report